Patuleia S, Moelans C, Koopman J, van Steenhoven J, van Dalen T, van der Pol C
BMC Cancer. 2022; 22(1):705.
PMID: 35761221
PMC: 9235076.
DOI: 10.1186/s12885-022-09795-8.
Jiwa N, Ezzat A, Holt J, Wijayatilake D, Takats Z, Leff D
Ann Med Surg (Lond). 2022; 77:103625.
PMID: 35638006
PMC: 9142541.
DOI: 10.1016/j.amsu.2022.103625.
Patuleia S, Suijkerbuijk K, van der Wall E, van Diest P, Moelans C
Cancers (Basel). 2022; 14(1).
PMID: 35008326
PMC: 8750428.
DOI: 10.3390/cancers14010159.
Jiwa N, Takats Z, Leff D, Sutton C
BMJ Nutr Prev Health. 2021; 4(1):206-212.
PMID: 34308128
PMC: 8258049.
DOI: 10.1136/bmjnph-2021-000266.
Patuleia S, van Gils C, Oneto Cao A, Bakker M, van Diest P, van der Wall E
Int J Mol Sci. 2020; 21(22).
PMID: 33187146
PMC: 7696615.
DOI: 10.3390/ijms21228466.
DNA promoter hypermethylation in nipple fluid: a potential tool for early breast cancer detection.
de Groot J, Moelans C, Elias S, Fackler M, van Domselaar R, Suijkerbuijk K
Oncotarget. 2016; 7(17):24778-91.
PMID: 27028854
PMC: 5029741.
DOI: 10.18632/oncotarget.8352.
Repeated nipple fluid aspiration: compliance and feasibility results from a prospective multicenter study.
de Groot J, Moelans C, Elias S, Hennink A, Verolme B, Suijkerbuijk K
PLoS One. 2015; 10(5):e0127895.
PMID: 26000714
PMC: 4441497.
DOI: 10.1371/journal.pone.0127895.
Non-invasive proteomics-thinking about personalized breast cancer screening and treatment.
Debald M, Wolfgarten M, Walgenbach-Brunagel G, Kuhn W, Braun M
EPMA J. 2012; 1(3):413-20.
PMID: 23199085
PMC: 3405342.
DOI: 10.1007/s13167-010-0039-9.
Aberrant promoter CpG methylation and its translational applications in breast cancer.
Xiang T, Yuan Y, Li L, Wang Z, Dan L, Chen Y
Chin J Cancer. 2011; 32(1):12-20.
PMID: 22059908
PMC: 3845590.
DOI: 10.5732/cjc.011.10344.
Successful oxytocin-assisted nipple aspiration in women at increased risk for breast cancer.
Suijkerbuijk K, van der Wall E, Meijrink H, Pan X, Borel Rinkes I, Ausems M
Fam Cancer. 2010; 9(3):321-5.
PMID: 20443067
PMC: 2921501.
DOI: 10.1007/s10689-010-9344-7.
